Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
The TROP2 ADC also awaits an FDA decision in EGFR-mutated lung cancer and a key readout in first-line non-small cell lung cancer in 2025.
Angus Liu
Jan 17, 2025 9:14pm
JPM25: Acadia’s new CEO sets sights on company's first $1B year
Jan 17, 2025 1:22pm
Sponsored
Privacy, Performance, and Emerging Media Channels: In Conversation with Jun Group
Oct 14, 2024 8:00am
Novartis wins 11th-hour bid to block Entresto generic from MSN
Jan 17, 2025 11:41am
Sponsored
How sponsors can meet the FDA’s diversity action plan requirements
Oct 14, 2024 8:00am
AZ's Calquence, Amgen's Lumakras win new FDA green lights
Jan 17, 2025 11:11am
